U.S. flag

An official website of the United States government

NM_001099857.5(IKBKG):c.337G>A (p.Asp113Asn) AND Immunodeficiency 33

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 15, 2004
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001172486.13

Allele description [Variation Report for NM_001099857.5(IKBKG):c.337G>A (p.Asp113Asn)]

NM_001099857.5(IKBKG):c.337G>A (p.Asp113Asn)

Gene:
IKBKG:inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq28
Genomic location:
Preferred name:
NM_001099857.5(IKBKG):c.337G>A (p.Asp113Asn)
HGVS:
  • NC_000023.11:g.154556314G>A
  • NG_009896.1:g.19071G>A
  • NM_001099856.6:c.541G>A
  • NM_001099857.5:c.337G>AMANE SELECT
  • NM_001145255.4:c.337G>A
  • NM_001321396.3:c.337G>A
  • NM_001321397.3:c.337G>A
  • NM_001377312.1:c.337G>A
  • NM_001377313.1:c.337G>A
  • NM_001377314.1:c.337G>A
  • NM_001377315.1:c.337G>A
  • NM_003639.4:c.337G>A
  • NP_001093326.2:p.Asp181Asn
  • NP_001093327.1:p.Asp113Asn
  • NP_001138727.1:p.Asp113Asn
  • NP_001308325.1:p.Asp113Asn
  • NP_001308326.1:p.Asp113Asn
  • NP_001364241.1:p.Asp113Asn
  • NP_001364242.1:p.Asp113Asn
  • NP_001364243.1:p.Asp113Asn
  • NP_001364244.1:p.Asp113Asn
  • NP_003630.1:p.Asp113Asn
  • LRG_70t1:c.337G>A
  • LRG_70:g.19071G>A
  • NC_000023.10:g.153784529G>A
  • NM_001099856.3:c.541G>A
  • NM_001099857.2:c.337G>A
  • NM_003639.3:c.337G>A
  • NR_165197.1:n.478G>A
  • Q9Y6K9:p.Asp113Asn
Protein change:
D113N; ASP113ASN
Links:
UniProtKB: Q9Y6K9#VAR_026493; UniProtKB/Swiss-Prot: VAR_026493; OMIM: 300248.0032; dbSNP: rs179363896
NCBI 1000 Genomes Browser:
rs179363896
Molecular consequence:
  • NM_001099856.6:c.541G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099857.5:c.337G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001145255.4:c.337G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001321396.3:c.337G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001321397.3:c.337G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001377312.1:c.337G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001377313.1:c.337G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001377314.1:c.337G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001377315.1:c.337G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_003639.4:c.337G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_165197.1:n.478G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Immunodeficiency 33 (IMD33)
Synonyms:
Immunodeficiency without anhidrotic ectodermal dysplasia; X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency
Identifiers:
MONDO: MONDO:0010386; MedGen: C1970879; Orphanet: 319605; Orphanet: 319612; OMIM: 300636

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001335516OMIM
no assertion criteria provided
Pathogenic
(Aug 15, 2004)
germlineliterature only

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Successful hematopoietic cell transplantation in patients with unique NF-κB essential modulator (NEMO) mutations.

Abbott JK, Quinones RR, de la Morena MT, Gelfand EW.

Bone Marrow Transplant. 2014 Nov;49(11):1446-7. doi: 10.1038/bmt.2014.157. Epub 2014 Jul 28. No abstract available.

PubMed [citation]
PMID:
25068423

IKBKG (nuclear factor-kappa B essential modulator) mutation can be associated with opportunistic infection without impairing Toll-like receptor function.

Salt BH, Niemela JE, Pandey R, Hanson EP, Deering RP, Quinones R, Jain A, Orange JS, Gelfand EW.

J Allergy Clin Immunol. 2008 Apr;121(4):976-82. doi: 10.1016/j.jaci.2007.11.014. Epub 2008 Jan 7.

PubMed [citation]
PMID:
18179816
PMCID:
PMC3050055
See all PubMed Citations (4)

Details of each submission

From OMIM, SCV001335516.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (4)

Description

In a boy (patient 1) with immunodeficiency-33 (IMD33; 300636), Abbott et al. (2014) identified a hemizygous c.337G-A transition in the IKBKG gene, resulting in an asp113-to-asn (D113N) substitution in the first coiled-coil domain. The patient had impaired NK cell function and impaired T-cell receptor signaling with decreased NFKB activity, but Toll-like receptor signaling appeared to be intact. He underwent successful bone marrow transplant. The patient had previously been reported in detail by Salt et al. (2008); his unaffected mother also carried the mutation.

Heller et al. (2020) identified a hemizygous D113N mutation in a boy with IMD33. His mother and grandmother, who were presumably unaffected, carried the heterozygous mutation. However, the proband's 40-year-old male cousin, who did not have recurrent infections and had normal response to polysaccharide antibodies, was hemizygous for D113N. Heller et al. (2020) noted that the allele frequency for this variant is rather high (0.009572), and that some suggest it may be a polymorphism (see Fusco et al., 2004).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024